Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
15 November 2017
Gavi welcomes new Global Fund Executive Director
24 October 2017
Gavi and the Aspen Institute to strengthen health management capacity in developing countries
16 October 2017
Attack on health facilities puts all Syrian children at risk
25 September 2017
Korea commits US$4 million to immunise children in world's poorest countries
23 August 2017
Gavi, the Vaccine Alliance welcomes Haiti's commitment to immunisation
20 July 2017
Vaccine progress in developing countries 'in danger of stalling'
10 July 2017
Gavi Board reappoints Chair and CEO
29 June 2017
Gavi welcomes US$ 1.5 million contribution from China Merchants Group
23 May 2017
Gavi welcomes election of new WHO Chief
22 May 2017
Immunisation at the 70th World Health Assembly
12 May 2017
Gavi stands ready to support the DR Congo in its fight against Ebola
24 April 2017
Partnership supports launch of malaria vaccine pilots in three African countries